A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...

Learn practical strategies to boost your confidence and own your style, even with a receding hairline. Embrace self-assurance every day with these tips.

Hereditary-patterned baldness, also called androgenic alopecia, affects people across genders, ages, and ethnic backgrounds.

This hair loss medication was FDA-approved in 1997 to treat AGA in men at a 1-milligram daily dose. At a higher 5-milligram dose, it’s approved to treat BPH. Minoxidil (brand name: Rogaine) is an ...

HAIFA, Israel and MIAMI, July 8, 2025 /CNW/ -- Insightec, a global healthcare innovator dedicated to using focused ultrasound to transform patient care, announced today that the U.S. Food and Drug ...

Androgenic alopecia, commonly known as male or female pattern baldness, affects millions worldwide, offering few treatment options with lasting efficacy. In a new study, researchers have unveiled a ...

Here are some of the products through Hims for anyone looking to tackle hair loss: Combining finasteride and minoxidil, this ...

REGN scores FDA approval for Lynozyfic in tough-to-treat multiple myeloma, bolstering its oncology pipeline amid Eylea headwinds.

At 2% and 5%, minoxidil is FDA-approved to treat androgenic alopecia (male pattern baldness and female pattern hair loss). It’s also used off-label to treat other types of hair loss, including: ...

“The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that ...

Verrica Pharmaceuticals Inc. board members let it conceal obstacles for regulatory approval of its lead product candidate, a shareholder lawsuit said.

The FDA has removed the Risk Evaluation and Mitigation Strategies (REMS) requirements for currently approved BCMA- and CD19-directed CAR-T therapies, the agency said Thursday.